Nephrol Dial Transplant (1996) 11: 444-448
© 1996 European Renal Association-European Dialysis and Transplant Association
research-article
Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration
1Institute of Medicina Clinica, University of Trieste, Ospedale di Cattinara Trieste, Italy 2Institute of Radiology, University of Trieste, Ospedale di Cattinara Trieste, Italy
Correspondence and offprint requests to: Correspondence and offprint requests to: Dr M. Carraro, Istituto di Medicina Clinica, Ospedale di Cattinara, Strada di Fiume 447, 34149 Trieste, Italy
BACKGROUND.: Although calcium-channel antagonists have been proposed as prophylaxis to prevent radiocontrast-induced nephropathy, the dose and dose interval to achieve a protective effect have not been quantified in humans.
METHODS.: In a randomized, double-blind protocol we studied urinary enzyme and microprotein excretion in 121 outpatients (mean age 65.3 ±9.3 years, 62% male) with normal renal function who were to undergo digital subtraction arteriography with iohexol or iopentol. The subjects were treated with a single dose of placebo (group 1) or nitrendipine 10 mg (group 2) or 20 mg (group 3) p.o. 1 h before the procedure. Blood and urine samples were collected 1 h before, 1 h after, and 24 h after contrast administration. Study variables included contrast volume and serum creatinine, and urinary creatinine, osmolality, albumin, alanylaminopeptidase (AAP, a brush border enzyme), N-acetyl-ß-glucosaminidase (NAG, a lysosomal enzyme), and 
-1-microglobulin (-1-micro, a filtered microprotein).
RESULTS.: Serum values of creatinine remained unchanged during the study period. Albuminuria was not affected by contrast administration, whereas AAP, NAG, and -1-micro increased significantly, all except AAP returning to baseline at 24 h. Pretreatment with nitrendipine did not reduce enzyme excretion, although AAP levels were lower in general in the group assigned to the 20-mg dose. Acute renal failure, defined as a 50% increase of serum creatinine 24 h after radiocontrast administration, was found in eight patients: four from group 1 (8.3%), three from group 2 (6.5%), and one from group 3 (3.7%).
CONCLUSIONS.: Neither the course of enzyme excretion nor the incidence of acute renal failure following radiocontrast administration were affected by single doses of calcium antagonists. AAP levels were lower in general in subjects taking the 20-mg dose of nitrendipine. This study also indicates that a single low or normal dose of nitrendipine per os is not effective prophylaxis before radiocontrast administration. The designs of future studies investigating the ‘nephroprotective’ effect of calcium-channel antagonists per os should incorporate (1) the use of repeated doses to saturate hepatic metabolic pathways, and (2) the control of confounding variables in the measurement of urinary enzymes.
Keywords: radiocontrast-induced nephropathy; calcium-channel antagonists; urinary enzymes
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. S. Waikar, K. D. Liu, and G. M. Chertow Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 844 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Toprak, M. Cirit, M. Tanrisev, C. Yazici, O. Canoz, M. Sipahioglu, A. Uzum, R. Ersoy, and E. Y. Sozmen Preventive effect of nebivolol on contrast-induced nephropathy in rats Nephrol. Dial. Transplant., March 1, 2008; 23(3): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pannu, N. Wiebe, M. Tonelli, and for the Alberta Kidney Disease Network Prophylaxis Strategies for Contrast-Induced Nephropathy JAMA, June 21, 2006; 295(23): 2765 - 2779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maeder, M. Klein, T. Fehr, and H. Rickli Contrast nephropathy: Review focusing on prevention J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1763 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Gami and V. D. Garovic Contrast Nephropathy After Coronary Angiography Mayo Clin. Proc., February 1, 2004; 79(2): 211 - 219. [Abstract] [PDF]
|
|
|
|
|
|
V. L. M. Esnault Radiocontrast media-induced nephrotoxicity in patients with renal failure: rationale for a new double-blind, prospective, randomized trial testing calcium channel antagonists Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1362 - 1364. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Huber, K. Ilgmann, M. Page, M. Hennig, U. Schweigart, B. Jeschke, L. Lutilsky, W. Weiss, H. Salmhofer, and M. Classen Effect of Theophylline on Contrast Material-induced Nephropathy in Patients with Chronic Renal Insufficiency: Controlled, Randomized, Double-blinded Study Radiology, June 1, 2002; 223(3): 772 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y-X J Wang, Y-F Jia, K-M Chen, and S K Morcos Radiographic contrast media induced nephropathy: experimental observations and the protective effect of calcium channel blockers Br. J. Radiol., December 1, 2001; 74(888): 1103 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Haylor and S. K. Morcos An oral ETA-selective endothelin receptor antagonist for contrast nephropathy? Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1336 - 1337. [Full Text] [PDF]
|
|